This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cheng, C.
Right arrow Articles by Sharp, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheng, C.
Right arrow Articles by Sharp, P. A.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, January 2006, p. 362-370, Vol. 26, No. 1
0270-7306/06/$08.00+0     doi:10.1128/MCB.26.1.362-370.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Regulation of CD44 Alternative Splicing by SRm160 and Its Potential Role in Tumor Cell Invasion

Chonghui Cheng1 and Phillip A. Sharp1,2*

Center for Cancer Research,1 Department of Biology, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 021392

Received 28 June 2005/ Returned for modification 11 August 2005/ Accepted 8 October 2005

The multiple isoforms of the transmembrane glycoprotein CD44 are produced by alternative RNA splicing. Expression of CD44 isoforms containing variable 5 exon (v5) correlates with enhanced malignancy and invasiveness of some tumors. Here we demonstrate that SRm160, a splicing coactivator, regulates CD44 alternative splicing in a Ras-dependent manner. Overexpression of SRm160 stimulates inclusion of CD44 v5 when Ras is activated. Conversely, small interfering RNA (siRNA)-mediated silencing of SRm160 significantly reduces v5 inclusion. Immunoprecipitation shows association of SRm160 with Sam68, a protein that also stimulates v5 inclusion in a Ras-dependent manner, suggesting that these two proteins interact to regulate CD44 splicing. Importantly, siRNA-mediated depletion of CD44 v5 decreases tumor cell invasion. Reduction of SRm160 by siRNA transfection downregulates the endogenous levels of CD44 isoforms, including v5, and correlates with a decrease in tumor cell invasiveness.


* Corresponding author. Mailing address: Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139-4307. Phone: (617) 253-6421. Fax: (617) 253-3867. E-mail: sharppa{at}mit.edu.


Molecular and Cellular Biology, January 2006, p. 362-370, Vol. 26, No. 1
0022-538X/06/$08.00+0     doi:10.1128/MCB.26.1.362-370.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Huot, M.-E., Vogel, G., Richard, S. (2009). Identification of a Sam68 Ribonucleoprotein Complex Regulated by Epidermal Growth Factor. J. Biol. Chem. 284: 31903-31913 [Abstract] [Full Text]  
  • Haque, A., Buratti, E., Baralle, F. E. (2009). Functional properties and evolutionary splicing constraints on a composite exonic regulatory element of splicing in CFTR exon 12. Nucleic Acids Res 0: gkp1040v1-gkp1040 [Abstract] [Full Text]  
  • Korner, M., Miller, L. J. (2009). Alternative Splicing of Pre-mRNA in Cancer: Focus on G Protein-Coupled Peptide Hormone Receptors. Am. J. Pathol. 175: 461-472 [Abstract] [Full Text]  
  • Paronetto, M. P., Messina, V., Bianchi, E., Barchi, M., Vogel, G., Moretti, C., Palombi, F., Stefanini, M., Geremia, R., Richard, S., Sette, C. (2009). Sam68 regulates translation of target mRNAs in male germ cells, necessary for mouse spermatogenesis. JCB 185: 235-249 [Abstract] [Full Text]  
  • Huot, M.-E., Brown, C. M., Lamarche-Vane, N., Richard, S. (2009). An Adaptor Role for Cytoplasmic Sam68 in Modulating Src Activity during Cell Polarization. Mol. Cell. Biol. 29: 1933-1943 [Abstract] [Full Text]  
  • Chawla, G., Lin, C.-H., Han, A., Shiue, L., Ares, M. Jr., Black, D. L. (2009). Sam68 Regulates a Set of Alternatively Spliced Exons during Neurogenesis. Mol. Cell. Biol. 29: 201-213 [Abstract] [Full Text]  
  • Du, L., Wang, H., He, L., Zhang, J., Ni, B., Wang, X., Jin, H., Cahuzac, N., Mehrpour, M., Lu, Y., Chen, Q. (2008). CD44 is of Functional Importance for Colorectal Cancer Stem Cells. Clin. Cancer Res. 14: 6751-6760 [Abstract] [Full Text]  
  • Wu, G. D., Wang, H., Zhu, H., He, Y., Barr, M. L., Klein, A. S. (2008). Genetic Modulation of CD44 Expression by Intragraft Fibroblasts. J Biochem 144: 571-580 [Abstract] [Full Text]  
  • Alpatov, R., Shi, Y., Munguba, G. C., Moghimi, B., Joo, J.-H., Bungert, J., Sugrue, S. P. (2008). Corepressor CtBP and Nuclear Speckle Protein Pnn/DRS Differentially Modulate Transcription and Splicing of the E-Cadherin Gene. Mol. Cell. Biol. 28: 1584-1595 [Abstract] [Full Text]  
  • David, C. J., Manley, J. L. (2008). The search for alternative splicing regulators: new approaches offer a path to a splicing code. Genes Dev. 22: 279-285 [Full Text]  
  • Paronetto, M. P., Achsel, T., Massiello, A., Chalfant, C. E., Sette, C. (2007). The RNA-binding protein Sam68 modulates the alternative splicing of Bcl-x. JCB 176: 929-939 [Abstract] [Full Text]  
  • Mangs, A. H., Speirs, H. J.L., Goy, C., Adams, D. J., Markus, M. A., Morris, B. J. (2006). XE7: A novel splicing factor that interacts with ASF/SF2 and ZNF265. Nucleic Acids Res 34: 4976-4986 [Abstract] [Full Text]  
  • Buratti, E., Baralle, M., Baralle, F. E. (2006). Defective splicing, disease and therapy: searching for master checkpoints in exon definition. Nucleic Acids Res 34: 3494-3510 [Abstract] [Full Text]  
  • Srebrow, A., Kornblihtt, A. R. (2006). The connection between splicing and cancer. J. Cell Sci. 119: 2635-2641 [Abstract] [Full Text]  
  • Cheng, C., Yaffe, M. B., Sharp, P. A. (2006). A positive feedback loop couples Ras activation and CD44 alternative splicing.. Genes Dev. 20: 1715-1720 [Abstract] [Full Text]